Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Ex Input:
His wife beat a more formidable challenger. Molly Crosby, a 32-year-old mother of five, had been dealing with bouts of coughing and congestion all summer. Some preliminary exams in Green Bay showed a spot on her right lung. That led the Crosbys to the Mayo Clinic in Rochester, Minn., for additional tests. A carcinoid endocrine tumor was found. The tumor isn't as dangerous as other forms of cancer but was disconcerting for an otherwise healthy, nonsmoker. "We found out the day before we reported to camp," Crosby said on Wednesday. "We were at Mayo the two or three days leading up to training camp, when they did all their scans and got the final prognosis." Crosby flew back to Green Bay for the start of training camp. After a subpar 2018 season, Crosby had to beat out Sam Ficken. Crosby managed to keep his focus and retained the job for a 13th season. "I've trained a long time in compartmentalizing different situations," Crosby said. "Whenever I was home, I was fully home. The organization was unbelievable through training camp, just giving me time to be with Molly and be with the family and help where I could throughout the day and evening. I just tried to be fully in on both things. I have felt a lot of freedom in this. "I love doing what I'm doing but the importance of taking care of family and being there for Molly and the kids, when I look back on it, it was a special camp. I was able to really fully immerse in both things. It was nerve-wracking, too. Day in and day out, it was coming in, having to work and compete at a high level, and then going home and flowing back into a normal routine. Then, we'd sit down at night and you'd remember that surgery was coming and Molly had cancer. Those things were heavy." That surgery was at the end of the preseason, with part of Molly's right lung removed. While she will go back to Mayo for a scan in mid-October, Crosby said the doctors are positive they got rid of the tumor and she will not require radiation or chemotherapy. Since 2009, the NFL has held its annual "Crucial Catch" campaign to raise money for the American Cancer Society. It was a campaign that had already hit home for Crosby. A grandmother died of breast cancer and a sister-in-law is in her third year battling ovarian cancer. Now with his wife's diagnosis, the fight against cancer has grown more meaningful. "That's what it's about is early detection," he said. "It's getting routine checkups. Don't take it for granted. The numbers, with our technology, are amazing with prevention but treating it if you catch it early enough. That's one of the big things is pushing that. Let's try to get earlier detection so we can fight this thing. "With Molly's cancer, it's always been really important to me but I'm going to continue to push the charge forward and make sure that everybody gets the care. We feel so fortunate with the care that we got. Hopefully, everybody gets the same care and the same prognosis that we got." The Packers (3-1) will play at the Dallas Cowboys (3-1) on Sunday. Some of Crosby's finest professional moments have happened at AT&T Stadium. In the 2010 season, the Packers won the Super Bowl in Arlington. A playoff game in the 2016 season against the Cowboys marked the highlight of his career. His 56-yard field goal with 1:33 to play gave the Packers a 31-28 lead. Dallas tied the score, but Crosby booted a 51-yarder on the final play for a 34-31 victory. "The two minutes in that game were the most exciting two minutes I think I've ever had in a game," he said. "To be able to execute it twice in that situation was awesome." ___ More AP NFL: https://apnews.com/NFL and https://twitter.com/AP_NFL

Ex Output:
Wife's cancer diagnosis hits home for Packers' Crosby.

Ex Input:
Diana Nyad cries as she speaks to reporters and fans after arriving back in Key West, Florida August 9, 2011. An asthma attack, a painful shoulder and battering wind and waves forced 61-year-old swimmer Diana Nyad to abandon early on Tuesday her bid to become the first person to swim from Cuba to Florida without a shark cage. REUTERS/Rob O'Neal/Florida Keys News Bureau/Handout The American, who tried and failed the 103-mile swim more than three decades ago when she was 28, gave up after enduring nearly 30 hours of a crossing expected to last 60, exhausted by her body's limits and the force of the elements. "I thought this was my time. We set out, thinking the conditions were favorable. They were not. The winds were stronger and the waves were bigger than what I'd expected," she told Reuters after her escort boat Bellisimo brought her to the Key West Yacht Club on Stock Island. Nyad, a veteran long-distance swimmer, had started out strongly, stroking rhythmically through calm seas after she dived off from the Marina Hemingway on the western outskirts of Cuba's capital Havana at 7:45 p.m. EDT on Sunday. But, she said in an interview with CNN, she suffered an unexpected bout of asthma that left her gasping for oxygen. An "excruciating pain" also developed in her right shoulder and these physical handicaps combined with contrary winds and seas that pushed her floundering off course. "Last night at midnight, I was trembling, the 11 hours of asthma had taken so much from my body ... I just knew that it wasn't mind over matter any more, I was absolutely spent," Nyad, wearing a white bathrobe, told CNN at Stock Island. She said that toward the end she was "limping" and "slapping around" in the water and even resorted to breast stroke instead of her usual crawl. Her doctor joined her in the water at one point to try to give her relief with an inhaler. CNN, which had a producer on one of the boats accompanying Nyad, said she was vomiting when she was brought aboard an escort boat at 12:45 a.m. EDT (0445 GMT) on Tuesday. Nyad, who later recovered to breakfast on scrambled eggs on her way to Key West, was disappointed but had no regrets about her motives for attempting the swim. She turns 62 this month. She had said her main aim in attempting the Cuba to Florida swim again, without a shark cage, was to help people her age and older realize they can still achieve many things. "I was the best person I could be ... that's the message. I dug down, I dug deep ... Whatever you're doing, do your job well," Nyad, who has the muscled body and the steely resolve of a marathon swimmer, told CNN. Raised in southern Florida, she first tried the crossing from Cuba in 1978, but failed in the face of winds and heavy waves. The same swim was completed successfully in May 1997 by Australian Susan Maroney, who was 22 at the time. But Maroney used a shark cage. Nyad's flotilla of escort vessels included specially equipped kayaks transmitting an anti-shark shield in the form of an electronic signal that is annoying to the sleek ocean predators that stalk the waters of the Florida Straits. When she was years younger, Nyad put herself into the record books by swimming around Manhattan in 1975 in less than eight hours and by completing a 102.5 mile swim from Bimini in the Bahamas to Florida in 1979. Despite her having to abandon her bid, her fans tweeted their admiration on Tuesday. "That was Diana's whole point. Rethink old. Sorry she (had) to abandon but my admiration doesn't waiver. Go Diana," said one. Asked whether she would attempt the swim again, Nyad told CNN: "You don't beat Mother Nature ... I think I'm going to have to go to my grave without swimming from Cuba to Florida."

Ex Output:
Sea defeats body, not spirit, of swimmer, 61.

Ex Input:
The Food and Drug Administration cleared a near-copy of the drug, dubbed Amjevita, developed by Amgen Inc. Regulators approved the drug for more than a half-dozen conditions listed on the original drug's label, including severe psoriasis and Crohn's diseases. Humira posted sales of nearly $15 billion in 2015 and was for many years the top-selling prescription drug in the world, according to data from IMS Health. It's the fourth time that the FDA has formally approved a so-called biosimilar, the industry term for a lower-cost version of a biotech drug. Biosimilar drugs, long available in Europe, are thought to have the potential to generate billions in savings for the U.S. health system. But currently only one biosimilar cleared by the FDA approval pathway is actually on the market in the U.S., Novartis' Zarxio, an alternative to Amgen's Neupogen that sells for about 15 percent less than the original product. The drug helps boost red blood cells in cancer patients. Amgen did not discuss plans for the drug's launch or price in a release issued Friday evening. But Wall Street analysts have noted that AbbVie claims it holds patents protecting Humira until at least 2022. They have previously estimated that Amgen's version could launch sometime between 2018 and 2022, depending on the outcome of court litigation. First approved in 2002, Humira accounted for 60 percent of AbbVie's total revenue last year. The injectable drug, which blocks chemicals linked to inflammation, is part of a family of biotech drugs including Enbrel and Remicade, which are also facing pending biosimilar competition. Development of lower-cost anti-inflammatory drugs is considered pivotal in reducing U.S. spending on specialty drugs, which has doubled to $150 billion since 2010, according to IMS Health. Thousand Oaks, California-based Amgen is itself a biotech powerhouse, and it too has medications facing competition from cheaper versions. The company is working to hedge those loses by developing lower-cost versions of competitors' drugs. AbbVie Inc. is based in North Chicago, Illinois.

Ex Output:
FDA approves lower-cost alternative to biotech drug Humira.